The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial

BACKGROUND: In the Italian Breast Cancer Intergroup Studies (IBIS) 3 phase III trial, we compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF) alone to sequential epirubicin/CMF regimens in patients with rapidly proliferating early breast cancer (RPEBC). We performed a post hoc analysis in t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ther Adv Med Oncol
Glavni autori: Bravaccini, Sara, Bronte, Giuseppe, Scarpi, Emanuela, Ravaioli, Sara, Maltoni, Roberta, Mangia, Anita, Tumedei, Maria Maddalena, Puccetti, Maurizio, Serra, Patrizia, Gianni, Lorenzo, Amaducci, Laura, Biglia, Nicoletta, Bounous, Valentina, Paradiso, Angelo Virgilio, Silvestrini, Rosella, Amadori, Dino, Rocca, Andrea
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2020
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7047424/
https://ncbi.nlm.nih.gov/pubmed/32158505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919888999
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items